N,N-Dimethyletonitazene

N,N-Dimethyletonitazene
Identifiers
  • 2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-dimethylethanamine
CAS Number
PubChem CID
Chemical and physical data
FormulaC20H24N4O3
Molar mass368.437 g·mol−1
3D model (JSmol)
  • CCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(C)C)C=CC(=C3)[N+](=O)[O-]
  • InChI=1S/C20H24N4O3/c1-4-27-17-8-5-15(6-9-17)13-20-21-18-14-16(24(25)26)7-10-19(18)23(20)12-11-22(2)3/h5-10,14H,4,11-13H2,1-3H3
  • Key:MYLQWWDDZNZULX-UHFFFAOYSA-N

N,N-Dimethyletonitazene is an opioid analgesic drug which has been sold as a designer drug, first detected in Latvia in May 2024.[1] It is far less potent than etonitazene, but still has a potency some 20x that of morphine.

References

  1. ^ "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.